Bone Biologics Corp (BBLG) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $1.15
• Market Cap: $2.08M
• EPS: $-2.40
• 52-Week High: $6.75
• 52-Week Low: $1.11

About Bone Biologics Corp

Bone Biologics Corp (BBLG) is an innovative medical device company focused on revolutionizing bone regeneration technologies, particularly in the spinal fusion sector. Utilizing proprietary recombinant human protein formulations, BBLG aims to enhance surgical outcomes and expedite patient recovery through its advanced regenerative solutions. Based in Burlington, Massachusetts, the company is strategically positioned to address critical clinical needs within orthopedics and spinal surgery, cat...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Bone Biologics Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does BBLG pay dividends?

Bone Biologics Corp (BBLG) does not currently pay a regular dividend.

What is BBLG's market cap?

Bone Biologics Corp (BBLG) has a market capitalization of $2.08M with a current stock price of $1.15.